The Launch of a Pioneering Genomic Study on Metabolic Health

Cook Islands communities in New Zealand are at the forefront of a new research initiative aimed at unraveling the genetic underpinnings of metabolic health. Launched in late 2025 by biotech firm Variant Bio in close collaboration with the University of Otago, this one-year study targets adults of Cook Islands descent living in Auckland. Led by experts including Professor Tony Merriman from Otago's Department of Biochemistry, the project seeks to identify genetic factors contributing to high rates of conditions like type 2 diabetes, obesity, gout, and kidney disease.

Recruitment is underway through the Pukapuka Community Group, with participants aged 18 and older invited to contribute blood samples, complete health questionnaires, and undergo phenotypic measurements such as body composition scans and vital signs checks. This effort builds on seven years of relationship-building with Pacific communities, emphasizing reciprocity and community-led governance.

The Urgent Metabolic Health Challenge for Pacific Peoples in New Zealand

Pacific peoples, including those from the Cook Islands, face disproportionately high burdens of non-communicable diseases (NCDs) in New Zealand. Recent health surveys reveal that around 65% of Pacific adults are classified as obese, compared to 31% of the general population. Diabetes prevalence stands at 12.7% among Pacific adults—more than double the national average—with projections indicating further rises by 2044 if trends continue.

In Cook Islands communities specifically, historical data from clinical audits show significant gestational diabetes rates, while migrant populations in NZ retain elevated risks due to dietary shifts from traditional foods to processed imports, urbanization, and genetic predispositions. A multi-year monitoring program in Rarotonga high schools found 60% of Year 9 students overweight or obese, underscoring the need for early intervention.

These statistics highlight metabolic syndrome—a cluster of conditions including high blood pressure, elevated blood sugar, excess body fat around the waist, and abnormal cholesterol levels—as a pressing public health issue. Addressing it requires innovative, culturally attuned research.

Spotlight on Cook Islands Communities: A Unique Genetic Perspective

Cook Islanders represent a distinct Polynesian group with rich genetic diversity shaped by isolation on Pacific atolls. The Pukapuka atoll, in particular, has drawn attention due to 1960s observations of unusually low cholesterol levels among residents, hinting at protective genetic adaptations.

Today, descendants in Auckland—part of New Zealand's 8,000-strong Cook Islands population—experience 'thrifty gene' effects, where evolutionary advantages for famine survival now exacerbate obesity and diabetes in calorie-abundant environments. This study's focus on Pukapuka descendants leverages this heritage to uncover variants that could inform therapies for broader Pacific and global populations.

University of Otago's Pivotal Role in the Collaboration

The University of Otago, renowned for its biomedical research, brings world-class expertise through Professor Tony Merriman, a leading gout geneticist. Merriman's prior work has identified metabolic disease risk factors in Māori and Pacific peoples, including mitonuclear discordance linked to gout, type 2 diabetes, and chronic kidney disease.

Otago's involvement ensures rigorous scientific oversight, from ethics protocols to data analysis. Recent Standley Fellow Temoe Neuffer, a University of Otago graduate, supports on-site coordination, exemplifying how higher education bridges community needs and cutting-edge genomics. This partnership exemplifies New Zealand universities' commitment to equitable health research.

Photo by Rob Cast on Unsplash

Study Methodology: From Recruitment to Genomic Insights

Participants undergo comprehensive assessments: informed consent, detailed questionnaires on diet, lifestyle, and family history; physical measurements like BMI, waist circumference, and blood pressure; and biosample collection via venipuncture for genetic sequencing.

Advanced phenotyping includes bioimpedance analysis for body fat distribution and point-of-care tests for glucose and lipids. Data will be analyzed using whole-genome sequencing to pinpoint variants associated with metabolic traits, with machine learning models linking genes to phenotypes.

• Ethical blood draws by trained nurses
• Community Kaitiaki Group oversight
• Results return to participants
• Long-term sample storage with consent

This step-by-step approach prioritizes participant safety and data sovereignty.

Empowering Communities Through Governance and Reciprocity

A hallmark is the Kaitiaki Group, comprising community leaders like Pukapuka Community Group President Nuku Rapana, who advises on study conduct, data use, and benefit-sharing. This model, co-developed over years, ensures findings benefit participants directly—such as personalized health reports—and contribute to drug discovery royalties shared equitably.

Past events, like returning 2023 Pukapuka study results, fostered trust, revealing high diabetes (25% participants) and gout prevalence, plus a rare high-frequency protective APOE variant explaining historical low cholesterol.

Related University-Led Initiatives in Pacific Metabolic Research

The University of Auckland's Liggins Institute drives the Ora'anga Tūmanava program, monitoring metabolic health in Rarotonga schools since 2016. Over 783 Year 9 students assessed, revealing alarming trends and informing a 2025 Health Promotion International paper on program evolution.

Jacquie Bay's team integrates checks into curricula, building youth health literacy. These efforts complement Otago's genomic focus, showcasing NZ universities' ecosystem tackling NCDs holistically. Explore higher ed career advice for roles in such impactful research.

Potential Impacts: From Genes to Global Therapies

Discoveries could yield targeted drugs, like those modulating APOE for cholesterol or novel gout pathways. For Pacific peoples, where diabetes control lags (only 36% at glycaemic targets vs 50% Europeans), personalized medicine promises equity.

Broader implications include informing NZ's Virtual Diabetes Register and national strategies, reducing the $2.5 billion annual NCD cost.

Photo by Ankara University on Unsplash

Overcoming Challenges in Pacific Health Research

Barriers include mistrust from colonial legacies, low research participation, and data silos. Solutions: community co-design, capacity-building (e.g., Otago training locals), and multi-stakeholder partnerships like Variant Bio-Novo Nordisk-Otago.

• Cultural tailoring of consent processes
• Addressing urbanization's dietary shifts
• Integrating traditional knowledge

These strategies enhance sustainability and relevance.

Future Directions and Opportunities in NZ Higher Education

As results emerge, expect publications advancing Pacific genomics. Universities like Otago seek researchers; check university jobs in biochemistry and public health. For career growth, visit higher ed career advice.

This study heralds a new era of inclusive research, potentially transforming metabolic health for Cook Islanders and beyond. Stay engaged via Rate My Professor for faculty insights.